Decoy Therapeutics is trading at $3.88, up +8.38%, with no clear catalyst identified.
- No new company-specific announcement dated August 17, 2026 was identified; the latest listed releases are from August 3.
- Q2 earnings released August 12 reported a $2.4 million loss and $228,000 revenue, but no direct link to the August 17 rise was reported.
- Broader indexes are mixed, so macro sentiment does not clearly explain the move.